Chengdu Kanghong Pharmaceutical Group Co., Ltd (SHE:002773)

Market Cap	40.98B
Revenue (ttm)	4.56B
Net Income (ttm)	1.22B
Shares Out	921.12M
EPS (ttm)	1.32
PE Ratio	33.65
Forward PE	n/a
Dividend	0.60 (1.42%)
Ex-Dividend Date	Jun 6, 2025

Volume	9,552,187
Average Volume	11,878,944
Open	41.66
Previous Close	44.49
Day's Range	41.66 - 47.37
52-Week Range	16.62 - 46.72
Beta	0.28
RSI	70.41
Earnings Date	Aug 28, 2025

About SHE:002773

Chengdu Kanghong Pharmaceutical Group Co., Ltd research, develops, manufactures, and distributes medicine for ophthalmic, neuropsychiatric and other applications in China. It also develops a pipeline of clinical and pre-clinical programs for ophthalmology, CNS, oncology, and common disease. Chengdu Kanghong Pharmaceuticals Group Co., Ltd. was founded in 1996 and is based in Chengdu, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1996
• Employees: 4,462
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002773

Financial Performance

In 2024, SHE:002773's revenue was 4.45 billion, an increase of 12.51% compared to the previous year's 3.96 billion. Earnings were 1.19 billion, an increase of 14.02%.